Table 4: Clinicopathological features of osetosarcoma tissue samples for chemosensitivity study.

Sample nameAgeGenderHistological subtypeSiteHuvos gradingPreoperation chemotherapy agentsMstastasis
(months)
Followup
(months)
Status

Huvos I

OS039FemaleTelangiectaticProximal femur1MTX, ADR/CDDP4654DOD
OS1713FemaleOsteoblasticProximal tibia1HD-MTX1551DOD
OS1814MaleOsteoblasticProximal tibia  1HD-MTX, ADR/CDDP 73NED
OS3219MaleOsteoblasticDistal femur1HD-MTX, CDDP/ADR, 47NED
OS3663FemaleOsteoblasticMetatarsus1IFO, CDDP/ADR18NED
OS4118MaleOsteoblasticPelvis1IFO, CDDP/ADRAt diagnosis18DOD
OS4714MaleChondroblasticProximal femur1IFO, CDDP/ADRAt diagnosis15AWD

Huvos III and IV

OS1119MaleOsteoblasticDistal tibia3HD-MTX, ADR/CDDP1888NED
OS2513MaleLi-FraumeniDistal femur3HD-MTX, ADR/CDDP4748DOD
OS2715FemaleOsteoblasticDistal femur3HD-MTX, IFO, ADR/CDDPAt diagnosis26DOD
OS3519FemaleFibroblasticDistal tibia3HD-MTX, CDDP/ADR40NED
OS3818MaleOsteoblasticDistal tibia3IFO, CDDP/ADR26NED
OS488MaleOsteoblasticProximal humerus3IFO, CDDP/ADR14NED
OS2414FemaleOsteoblasticDistal femur4HD-MTX, CDDP/ADR,60NED
OS289FemaleOsteoblasticProximal tibia4HD-MTX, CDDP/ADR,651NED
OS3916MaleChondroblasticProximal tibia4IFO, CDDP/ADR26NED